Stacy M. Moore, Ph.D. - Publications
Affiliations: | 2000 | Johns Hopkins University, Baltimore, MD |
Area:
Pharmacology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2001 | Moore SM, Cannon JS, Tanhehco YC, Hamzeh FM, Ambinder RF. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrobial Agents and Chemotherapy. 45: 2082-91. PMID 11408227 DOI: 10.1128/Aac.45.7.2082-2091.2001 | 0.513 | |||
1999 | Cannon JS, Hamzeh F, Moore S, Nicholas J, Ambinder RF. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Journal of Virology. 73: 4786-93. PMID 10233939 DOI: 10.1128/Jvi.73.6.4786-4793.1999 | 0.594 | |||
1999 | Ambinder RF, Lemas MV, Moore S, Yang J, Fabian D, Krone C. Epstein-Barr virus and lymphoma. Cancer Treatment and Research. 99: 27-45. DOI: 10.1007/978-0-585-38571-6_2 | 0.41 | |||
1998 | Walker TR, Moore SM, Lawson MF, Panettieri RA, Chilvers ER. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: Role in mediating airway smooth muscle proliferation Molecular Pharmacology. 54: 1007-1015. PMID 9855629 DOI: 10.1124/mol.54.6.1007 | 0.34 | |||
1997 | Moore SM, Ambinder RF. Pharmacologic induction of Epstein-Barr Virus lytic cycle Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A41. DOI: 10.1097/00042560-199704010-00142 | 0.474 | |||
1996 | Ambinder RF, Robertson KD, Moore SM, Yang J. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Seminars in Cancer Biology. 7: 217-26. PMID 8946606 DOI: 10.1006/Scbi.1996.0029 | 0.6 | |||
Show low-probability matches. |